The global active pharmaceutical ingredients (API) market report offers in-depth analysis of the market size (revenue), market share, major market segments, different geographic regions, key players, premium insights, technology trends and forecast to 2022. It also focuses on the key drivers and opportunities in this market.
Chicago, IL -- (SBWIRE) -- 03/07/2017 -- According to the new market research report, "Active Pharmaceutical Ingredients (API) Market, by Manufacturer (Captive, Merchant), Synthesis (Synthetic, Biological), Drug Type (Generics, Branded), Classification (HPAPI, Others), Therapeutic Area (Cardiovascular Disorders, Metabolic Disorders, CNS, Oncology, Musculoskeletal Diseases, NSAIDs, Others) - Global Revenue, Trends, Growth, Share, Size and Forecast to 2022", published by Scalar Market Research, the global active pharmaceutical ingredient (API) market is expected to grow at a steady CAGR of 6.4% and reach USD 224.63 billion by the year 2022.
Request Sample: https://www.scalarmarketresearch.com/request-sample.php?id=30
Early buyers will receive 10% free customization on this report.
Key findings of the report:
According to the report, the rapid advancements in biologics are one of the major driving factors for the global active pharmaceutical ingredients (API) market.
Apart from that, the rising local manufacturing and the growth in the number of aging population are also expected to drive the global active pharmaceutical ingredient (API) market during the forecast period.
The increasing awareness towards generic drugs and the growing government initiatives are also expected to boost the growth of the active pharmaceutical ingredients (API) market during the forecast period.
Detailed segmentation analysis of the active pharmaceutical ingredients (API) market
The report segments the global active pharmaceutical ingredient (API) market by manufacturers, synthesis, drug types, classifications, therapeutic areas, and geographic regions. The manufacturer segments are further divided into merchant and captive. The synthesis segment includes biological and synthetic. The drug types include generic and branded. The classifications include HPAPI and others. The therapeutic areas include metabolic disorders, cardiovascular diseases, NSAIDs, CNS, musculoskeletal diseases, oncology, and others. Based on the geographic regions, the global active pharmaceutical ingredient (API) market is further divided into North America, Asia-Pacific, Europe, and Rest of the World.
The active pharmaceutical ingredients (API) market report provides analysis of the key players, including:
Teva Pharmaceutical Industries, Ltd
Sun Pharmaceutical Industries Ltd
Dr.Reddy's Laboratories
Aurobindo Pharma Ltd
Mylan N.V
Novartis AG
Cambrex Corporation
Boehringer Ingelheim GmbH
Pfizer, Inc
Lonza Group
Browse Report Summary: https://www.scalarmarketresearch.com/market-reports/active-pharmaceutical-ingredients-api-market
About Scalar Market Research
Scalar Market Research is a portfolio company of ALCOR GROUP, a Chicago, U.S.-based Mergers & Acquisitions giant with immense experience and connection with more than 1500 global funds which include leading Angel, VC, PE, Hedge, LBO, and Buyout Funds. ALCOR also deals in other services including Fund & Asset Management, Private Equity, and Corporate Finance. Our strong connection with the ALCOR GROUP of companies gives us an extra edge in delivering unique business intelligence.
Our real-time industry data tracking, with the help of advanced analytics and machine learning, offers our clients highly accurate 360-degree perspective of key developments in niche markets. Our team of industry experts, with a thorough understanding of global markets and cumulative industry experience spanning 100+ years, works relentlessly to help our clients realize their most important business goals.
Find out more about our services at: www.scalarmarketresearch.com